Treating Acutely Agitated Patients With Asenapine Sublingual Tablets
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Our proposal is to administer asenapine to patients who are clinically agitated and in need
of immediate intervention. At present there are no controlled studies that we know of that
explores the use of asenapine for this purpose. Establishing the utility of asenapine for
this common clinical problem will support its use as an additional treatment option in
acutely agitated patients.
Phase:
Phase 4
Details
Lead Sponsor:
St. Joseph Hospital Health Center Unity Health Toronto